Erasmus University Reports Research In Prostate Cancer Therapy
May-10-2007
Researchers detail in "Side-effects of treatment for localized prostate cancer: are they valued differently by patients and healthy controls," new data in prostate cancer. "To determine how men treated for localized prostate cancer and who had permanent side-effects, and healthy controls, would value five descriptions of health states associated with side-effects of treatment for localized prostate cancer, hypothesising that patients would value the health states as less detrimental than men with no prostate cancer. In previous research, patients with prostate cancer reported high generic quality-of-life scores after primary treatment, despite side-effects; it was suggested that these patients accepted the side-effects, i.e. urinary, bowel...
Athletes Team Up In The Fight Against Prostate Cancer
May-10-2007
SANTA MONICA, Calif. -- The Prostate Cancer Foundation announced today the launch of a national public service campaign encouraging men with prostate cancer to seek the advice of an integrated team of health care professionals -- a urologist, a radiation oncologist and a medical oncologist -- to optimize their treatment. As part of the fundraising and awareness effort called Athletes for a Cure, the new campaign will consist of television and radio PSAs featuring nationally-recognized sportscaster Trey Wingo, as well as other Athletes touched by prostate cancer. "When my father and father-in-law were diagnosed with prostate cancer, I became an active participant in their care and helped them to assemble a team of spec...
Prostate Cancer Symptoms - What You Should Know
May-08-2007
The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system; it wraps around the urethra, the tube that carries urine out of the body - because of this can cause various urinary problems. Early prostate cancer is confined to the prostate gland itself; most of the patients with this type of cancer can live for years without any problems. Detected in its early stages, prostate cancer can be effectively treated and cured. Prostate cancer is deadly, but because...
Reports From University Of California Advance Knowledge In Prostate Cancer Therapy
May-10-2007
Data detailed in "Adrenal androgen levels as predictors of outcome in prostate cancer patients treated with ketoconazole plus antiandrogen withdrawal: results from a cancer and leukemia group B study" have been presented. "Adrenal androgens activate the androgen receptor and stimulate prostate cancer growth. Ketoconazole is used as an inhibitor of adrenal androgen synthesis in men with androgen-independent prostate cancer," researchers in the United States report. "This study analyzes the relationship between pretreatment androgen levels and outcome following ketoconazole treatment. Baseline levels of three adrenal androgens (androstenedione, dehydroepiandrostenedione, and dehydroepiandrostenedione-sulfate) and testosterone were measured...
Prostate Cancer - Symptoms Treatment And Diet
May-08-2007
If you have prostate cancer, are concerned about getting it, or if you're looking out for the health of someone you love, this article can help. Prostate cancer is normally a slow growth cancer that can take years before it becomes deadly. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system; it wraps around the urethra, the tube that carries urine out of the body - because of this can cause various urinary problems. Like other cancers, the cause of ...
New Study Shows That Cesium-131 From IsoRay Medical(TM) Is an Effective, Well-Tolerated Brachytherapy Treatment for Prostate Cancer with Fewer Side Effects Than Other Medical Isotopes: Brian Moran, MD, Founder and Principal of the Chicago ProstateCancer Center, Presents His Findings at the 28th AmericanBrachytherapy Society Annual Meeting in Chicago
May-08-2007
Brian Moran, MD, founder and principal of the Chicago Prostate Cancer Center (CPCC) presented the results of his two-year investigation into key characteristics of Cesium-131 at the 28th American Brachytherapy Society Annual Meeting, held in Chicago April 29th through May 1, 2007. Dr. Moran concluded that the medical isotope is effective and well-tolerated in its use to kill cancer cells in low dose (LDR) brachytherapy therapy for the treatment of prostate cancer. [PRWEB May 1, 2007]
Serial Markers Of Bone Turnover In Men With Metastatic Prostate Cancer Treated With Zoledronic Acid For Detection Of Bone Metastases Progression
May-06-2007
UroToday.com- Presently, bone imaging to include bone scans is used to determine the progression of prostate cancer (CaP) metastatic to bone. In patients with bone involvement, zoledronic acid (ZA) is shown to reduce skeletal related events. A report in the online version of European Urology by Dr. [click link for full article]
Obesity Is Associated With Increased Risks Of Prostate Cancer Metastasis And Death After Initial Cancer Diagnosis In Middle-Aged Men
May-06-2007
UroToday.com- In the online edition of Cancer, Dr. Gong and associates from Seattle, Washington report on a population-based cohort of middle-aged men that links obesity at the time of diagnosis with increased risk of prostate cancer (CaP) metastasis and death. [click link for full article]
Prostate Cancer, Prostate Cancer
May-08-2007
The prostrate is a gland found only in males and located in front of the rectum on the neck of the bladder It is a walnut sized gland about 3 cm in size that encircles the urethra The prostrate produces seminal fluids and along with the sperm received from the testes releases the semen into the urethra during ejaculation It also prevents the semen from flowing back into the bladder
Study implicates protein as a trigger of advanced prostate cancer recurrence
May-08-2007
Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to...
Study implicates protein as a trigger of advanced prostate cancer recurrence
May-07-2007
Scientists with the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill have for the first time implicated a growth-promoting cellular protein as one trigger of the inevitable recurrence of advanced prostate cancer in men who are undergoing drug treatment to shut down their sex hormones, or androgens.
MR Imaging Helps Predict Recurrence In Prostate Cancer Patients
May-07-2007
MR images taken of prostate cancer patients prior to treatment that show that the cancer has spread outside the prostate gland capsule help predict whether the cancer will return, according to a recent study conducted by radiologists at the University of California-San Francisco.
Cesium-131 From IsoRay Medical (TM), Inc. Established as a Front Line Treatment for Early Stage Prostate Cancer Treatment in a Recent Clinical Trial: Results Unveiled by Renowned Researchers at American BrachytherapySociety (ABS) Annual Meeting
May-08-2007
Investigators of a recent multi-institutional trial, led by principal investigator Bradley Prestidge, conclude that Cesium-131, a medical isotope used in low dose (LDR) brachytherapy treatment for prostate cancer, "... has come into widespread use; and the clinical results of this trial are mature enough to be of immediate, important, practical use to practitioners." [PRWEB May 1, 2007]
New Prostate Cancer Treatment Wins Operations Research Award For Sloan-Kettering
May-07-2007
Main Category: Prostate / News Article Date: 06 May 2007 - 21:00 PDT The unique application of operations research to the treatment of prostate allowed Memorial Sloan-Kettering Cancer ...